Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Giant Cell Arteritis
|
78 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Osteoarthritis, Knee
|
150 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Systemic Scleroderma
|
287 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.020 | 0.500 | 2 | 2011 | 2016 | |||||
Malignant Neoplasms
|
1641 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.020 | 1.000 | 2 | 2012 | 2017 | |||||
Obesity
|
1111 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.020 | 1.000 | 2 | 2012 | 2015 | |||||
Primary malignant neoplasm
|
1374 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.020 | 1.000 | 2 | 2012 | 2017 | |||||
Pregnancy associated hypertension
|
43 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Serum albumin measurement
|
3282 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Coronary Artery Disease
|
1577 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.060 | 1.000 | 6 | 2013 | 2018 | |||||
Bladder Neoplasm
|
281 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.020 | 0.500 | 2 | 2013 | 2017 | |||||
Carcinoma of bladder
|
309 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.020 | 0.500 | 2 | 2013 | 2017 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.020 | 0.500 | 2 | 2013 | 2017 | |||||
Centriacinar Emphysema
|
3 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Diabetic foot ulcer
|
17 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Paraseptal emphysema
|
3 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Aortic Aneurysm, Abdominal
|
90 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||
Cardiovascular Diseases
|
711 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Ischemic stroke
|
704 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.060 | 1.000 | 6 | 2015 | 2020 | |||||
Behcet Syndrome
|
243 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1 | 2015 | 2015 | ||||||
Liver diseases
|
100 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Non-alcoholic Fatty Liver Disease
|
222 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Psoriasis vulgaris
|
80 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Chronic Obstructive Airway Disease
|
852 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.020 | 1.000 | 2 | 2016 | 2016 | |||||
Coronary Arteriosclerosis
|
440 | 0.602 | 0.680 | 20 | 46007337 | upstream gene variant | C/T | snv | 0.14 | 0.020 | 1.000 | 2 | 2016 | 2017 |